We have identified 65 global erythropoietin tenders from the public procurement domain worldwide. View the latest global tenders for erythropoietin from Africa, the Americas, Asia, Australia, Europe, the Middle East, and other countries. Find global tender information, RFPs, RFQs, ICBs, bidding contracts, and invitations to bid for erythropoietin tenders published by various government departments, the World Bank, the United Nations, multilateral funding agencies, military, defense, and private companies across the world.
Tenders Are Invited For Unified Purchasing Dictionary Dk 021:2015: 33600000-6 - Pharmaceutical Products (Electrolytes And Combination Solutions For Infusions, 500 Ml Each (Electrolytes); Enoxaparin Sodium, Solution For Injections, 10000 Anti-Ha Mo/Ml, 5.0 Ml Each (Enoxaparin); Erythropoietin Alfa, Solution For Injections, 1 Ml, Glucose Solution For Infusions, 200 Ml (Glucose), Solution For Infusions, 5% (Glucose), Solution For Injections, 500 Mg/Ml, 2 Ml; Sodium Chloride, Solution For Infusions, 9 Mg/Ml 100 Ml (Sodium Chloride, Solution For Infusions...
Tenders Are Invited For Pharmaceutical Products - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Erythropoietin (Exclusively Epoetin Alfa And Zeta), Atc B03xa01 For The Period July 1St, 2026 - June 30Th, 2028
Tenders Are Invited For Pharmaceutical Products - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Epoetin Alfa (Genetically Engineered Human Erythropoietin - Limitation To Packs With A Dosage Of Up To 10,000 Iu)
Tenders Are Invited For Pharmaceutical Products – Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Epoetin Zeta (Recombinant Human Erythropoietin)
Tenders Are Invited For Pharmaceutical Products - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Erythropoietin Exclusively Epoetin Alfa, (Obo) Atc B03xa01 For The Period March 1St, 2025 - February 28Th, 2027
Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For Various Active Ingredients/S/Combinations With The Possibility Of Conclusion At Any Time As Part Of The So-Called Open House Procedure
Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For Various Active Ingredients/S/Combinations With The Possibility Of Conclusion At Any Time As Part Of The So-Called Open House Procedure
